Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT
David F. Jarrard, MD close
ZEZIJdPU

David F. Jarrard, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Jarrard is board certified by the American Board of Urology and has completed a fellowship in Urologic Oncology. He specializes in all aspects of urologic oncology with an emphasis on prostate cancer diagnosis and treatment. Dr. Jarrard is also involved with surgical treatments for prostate cancer, such as the robotic prostatectomy.

Specialties

Urology

UW Health Clinics

UW Carbone Cancer Center
(608) 263-4757 | (800) 323-8942 | Map
UW Hospital and Clinics
(608) 263-4757 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)
Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Urology

Professional Certifications and Education

Board Certification Urology
Fellowship

Urologic Oncology, Johns Hopkins Hospital, Baltimore, MD


Residency University of Chicago Medical Center, Chicago, IL
Internship University of Chicago Medical Center, Chicago, IL
Medical School University of Virginia School of Medicine, Charlottesville, VA, 1989

Awards/Honors

Madison Magazine Top Docs 2014

Best Doctors® in America 2014

Best Doctors® in America 2013

Madison Magazine Top Docs 2012

Best Doctors® in America 2011


Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Procedures

Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Research

Dr. Jarrard has a joint appointment with the University of Wisconsin Carbone Cancer Center, and his clinical research emphasizes developing new therapies for genitourinary cancers. He has an active basic science laboratory and is funded through the National Institutes of Health to examine genetic and epigenetic alterations in prostate cancer.


PubMed Articles

PubMed articles are currently unavailable.